You are here

GeneTether Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
GTTX
CSE Index: 
Currency: 

GeneTether Therapeutics is an innovative genetic medicines company focused on creating best-in-class gene editing therapies based on our proprietary GeneTether™ platform. Our platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs. We use a proprietary method to “tether” donor DNA templates to the genome editing complex, making the template readily available for use during the genome editing repair stage.

You are here

GeneTether Therapeutics Inc. (GTTX)

SEDAR Information

Company Info

Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
Canada
Phone
(514) 796-2640
Email
Roland@genetether.com
Website
https://www.genetether.com
Listing date
Monday, March 28, 2022
Transfer Agent
Odyssey Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
41,666,648
Reserved for Issuance: 
17,942,855

Company Officers

Roland Boivin, Chief Executive Officer
Daren Graham, Chairman
R. Geoffrey Sargent, Chief Scientific Officer
Jean Jen, Chief Financial Officer and Corporate Secretary

Bulletins

28/03/2022

2022-0339 - New Listing - GeneTether Therapeutics Inc. (GTTX)

le 28 mars/March 2022

The common shares of GeneTether Therapeutics Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Website_2.jpg

Capital Markets Comeback Tour

Wednesday, May 11, 2022 to Thursday, June 2, 2022
VRIC_1200x675.jpg

Vancouver Resource Investment Conference (VRIC)

Tuesday, May 17, 2022 - 8:30am to Wednesday, May 18, 2022 - 5:30pm